The global food allergy diagnostics and therapeutics market size is expected to reach USD 13.28 billion by 2030, registering a CAGR of 8.0% during the forecast period, according to a new report. The market is expected to grow in the coming years owing to increasing incidence of food allergies coupled with rising demand for products for management of these conditions.
Medical was the largest application for PEG, accounting for more than 40% of market share in 2022. Superior blending, hygroscopicity, and non-toxic properties of PEG have resulted in high demand for the chemical in numerous pharmaceutical products such as tablets and ointments. Increasing pharmaceutical expenditure, particularly in emerging economies of India, China, and Brazil, is expected to boost PEG market over the forecast period. Growing demand for paints & coatings coupled with the increasing use of PEG as a solvent due to its low VOC emissions is anticipated to fuel market growth over the next six years.
However, administering epinephrine using an auto-injector during the early stage of anaphylaxis might help avoid any serious complications. Treatment for food allergy costs around USD 25 billion annually in the U.S. Development of cost-effective in vitro diagnostic tests for detection of allergy is expected to fuel the demand for diagnostic products.
This product will be delivered within 1-3 business days.
Medical was the largest application for PEG, accounting for more than 40% of market share in 2022. Superior blending, hygroscopicity, and non-toxic properties of PEG have resulted in high demand for the chemical in numerous pharmaceutical products such as tablets and ointments. Increasing pharmaceutical expenditure, particularly in emerging economies of India, China, and Brazil, is expected to boost PEG market over the forecast period. Growing demand for paints & coatings coupled with the increasing use of PEG as a solvent due to its low VOC emissions is anticipated to fuel market growth over the next six years.
However, administering epinephrine using an auto-injector during the early stage of anaphylaxis might help avoid any serious complications. Treatment for food allergy costs around USD 25 billion annually in the U.S. Development of cost-effective in vitro diagnostic tests for detection of allergy is expected to fuel the demand for diagnostic products.
Food Allergy Diagnostics And Therapeutics Market Report Highlights
- Therapeutics segment dominated the market in 2023 due to growing demand for antihistamines and epinephrine auto-injector
- Diagnostic segment includes instruments, consumables, and services, wherein consumables expected to grow at the fastest CAGR during the forecast period
- The most common tests used to diagnose food allergies are skin prick tests and blood tests
- Peanut allergen source segment is anticipated to register lucrative growth over the forecast period, owing to novel product launches coupled with rising incidence of peanut allergies worldwide.
- Hospitals & clinics dominated the food allergy diagnostics & therapeutics market in 2023 owing to increase in number of hospitalizations due to severe allergic conditions
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Food Allergy Diagnostics and Therapeutics Market Variables, Trends, & Scope
Chapter 4. Food Allergy Diagnostics and Therapeutics Market: Product Estimates & Trend Analysis
Chapter 5. Food Allergy Diagnostics and Therapeutics Market: Allergen Source Estimates & Trend Analysis
Chapter 6. Food Allergy Diagnostics and Therapeutics Market: End use Estimates & Trend Analysis
Chapter 7. Food Allergy Diagnostics and Therapeutics Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
Companies Mentioned
- Allergy Therapeutics
- Cambridge Allergy Limited
- Astellas Pharma, Inc
- Immunomic Therapeutics, Inc
- Prota Therapeutics Pty Ltd
- Aimmune Therapeutics
- Meridian Medical Technologies
- ALK-Abello Ltd
- Medeca Pharma AB
- bioMerieux SA
- Omega Diagnostics Group PLC
- HYCOR Biomedical
- HOB Biotech Group PLC
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 100 |
Published | July 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 7.91 Billion |
Forecasted Market Value ( USD | $ 13.28 Billion |
Compound Annual Growth Rate | 8.0% |
Regions Covered | Global |
No. of Companies Mentioned | 13 |